SCHEMBL1144648

SCHEMBL1144648

COc1ccc2c(C=O)c(Cl)n(-c3ccccc3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 2/20 0.44
HTT P42858 3/20 0.43
MAPT P10636 1/20 0.43
MAT2A P31153 1/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK8 P45983 4/20 0.42
EDNRA P25101 1/20 0.42
MAPK1 P28482 1/20 0.40
MAPK10 P53779 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
NTRK1 P04629 1/20 0.39
IGF1R P08069 1/20 0.39
FGFR1 P11362 1/20 0.39
NTRK2 Q16620 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144602 0.90 KDM4E (0.53) KDM4EALDH1A1HTTMAPTHPGD
SCHEMBL1144244 0.87 ALDH1A1 (0.42) KDM4EALDH1A1HTTMAPTHPGD
SCHEMBL2348590 0.84 CYP1A2 (0.46) HTTHPGDCYP1A2CYP3A4CYP2C19
SCHEMBL2345502 0.84 HPGD (0.54) KDM4EALDH1A1HTTMAPTHPGD
SCHEMBL1144571 0.82 MAT2A (0.51) MAT2ACYP1A2MAPK8
SCHEMBL1144857 0.79 KDM4E (0.60) KDM4EALDH1A1HTTMAPTMAT2A
SCHEMBL1144030 0.79 MAT2A (0.40) MAT2AMAPK8
SCHEMBL1149897 0.79 MAT2A (0.41) MAT2AMAPK8FGFR1
SCHEMBL29954953 0.78 KDM4E (0.52) KDM4EALDH1A1HTTMAPTCYP1A2
SCHEMBL2343158 0.78 KDM4E (0.52) KDM4EALDH1A1HTTMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2247575-B1 CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2016-03-23 EP disclosed
US-8211885-B2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals SANOFI-AVENTIS (FR) 2012-07-03 US disclosed
US-20110039830-A1 CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (FR) 2011-02-17 US disclosed
EP-2247575-A2 CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS Sanofi-Aventis (FR) 2010-11-10 EP disclosed
WO-2009095163-A2 CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (FR) 2009-08-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039830-A1 CYCLIC INDOLE-3-CARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS REN, ACE, PM20D2 KDM4E 958/4885ALDH1A1 2427/4885HTT 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.